These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 7807700)

  • 1. [A study on effectiveness of treatment and prevention of relapse using topical administration of terbinafine in a guinea pig model for tinea pedis].
    Uchida K; Kudoh M; Yamaguchi H
    Jpn J Antibiot; 1994 Oct; 47(10):1407-12. PubMed ID: 7807700
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Effectiveness of oral treatment with terbinafine in a guinea pig model of tinea pedis].
    Uchida K; Yamaguchi H
    Jpn J Antibiot; 1994 Oct; 47(10):1401-6. PubMed ID: 7807699
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Achievement of complete mycological cure by topical antifungal agent NND-502 in guinea pig model of tinea pedis.
    Uchida K; Tanaka T; Yamaguchi H
    Microbiol Immunol; 2003; 47(2):143-6. PubMed ID: 12680717
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Therapeutic efficacy of topically applied KP-103 against experimental tinea unguium in guinea pigs in comparison with amorolfine and terbinafine.
    Tatsumi Y; Yokoo M; Senda H; Kakehi K
    Antimicrob Agents Chemother; 2002 Dec; 46(12):3797-801. PubMed ID: 12435679
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Topical treatment with butenafine significantly lowers relapse rate in an interdigital tinea pedis model in guinea pigs.
    Arika T; Yokoo M; Yamaguchi H
    Antimicrob Agents Chemother; 1992 Nov; 36(11):2523-5. PubMed ID: 1489197
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Topical butenafine for tinea pedis.
    Med Lett Drugs Ther; 1997 Jul; 39(1004):63-4. PubMed ID: 9217695
    [No Abstract]   [Full Text] [Related]  

  • 7. Treatment of interdigital tinea pedis with a 4-week once-daily regimen of butenafine hydrochloride 1% cream.
    Tschen E; Elewski B; Gorsulowsky DC; Pariser DM
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S9-14. PubMed ID: 9039199
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of butenafine hydrochloride, a new benzylamine derivative, on experimental tinea pedis in guinea pigs.
    Arika T; Yokoo M; Maeda T; Amemiya K; Yamaguchi H
    Antimicrob Agents Chemother; 1990 Nov; 34(11):2254-5. PubMed ID: 2073117
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Double-blind study of the efficacy of 1 week topical terbinafine cream compared to 4 weeks miconazole cream in patients with tinea pedis.
    Leenutaphong V; Niumpradit N; Tangwiwat S; Sritaveesuwan R; Muanprasat C
    J Med Assoc Thai; 1999 Oct; 82(10):1006-10. PubMed ID: 10561963
    [TBL] [Abstract][Full Text] [Related]  

  • 10. One-week therapy with twice-daily butenafine 1% cream versus vehicle in the treatment of tinea pedis: a multicenter, double-blind trial.
    Savin R; De Villez RL; Elewski B; Hong S; Jones T; Lowe N; Lucky A; Reyes B; Stewart D; Willis I
    J Am Acad Dermatol; 1997 Feb; 36(2 Pt 1):S15-9. PubMed ID: 9039200
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tinea pedis: clinical experience and efficacy of short treatment.
    Evans EG
    Dermatology; 1997; 194 Suppl 1():3-6. PubMed ID: 9154392
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Topical terbinafine. Reduction of duration of therapy for tinea pedis].
    Schmid-Wendtner MH; Korting H
    Hautarzt; 2008 Dec; 59(12):986-91. PubMed ID: 18987841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Efficacy and safety of a new single-dose terbinafine 1% formulation in patients with tinea pedis (athlete's foot): a randomized, double-blind, placebo-controlled study.
    Ortonne JP; Korting HC; Viguié-Vallanet C; Larnier C; Savaluny E
    J Eur Acad Dermatol Venereol; 2006 Nov; 20(10):1307-13. PubMed ID: 17062050
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic type tinea pedis.
    Kikuchi I; Tanuma H; Morimoto K; Kawana S
    Mycoses; 2008 Jan; 51(1):7-13. PubMed ID: 18076589
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effectiveness of treatment of severe tinea pedis with 1% terbinafine cream in members of the Japanese self-defense forces.
    Noguchi H; Hiruma M; Kawada A
    Mycoses; 1999; 42(7-8):479-84. PubMed ID: 10546490
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Seven days of intermittent terbinafine 250 mg treatment in Tinea pedis].
    Hamaguchi T; Takiuchi I
    Nihon Ishinkin Gakkai Zasshi; 2002; 43(2):79-83. PubMed ID: 12040364
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparable efficacy and safety of various topical formulations of terbinafine in tinea pedis irrespective of the treatment regimen: results of a meta-analysis.
    Korting HC; Kiencke P; Nelles S; Rychlik R
    Am J Clin Dermatol; 2007; 8(6):357-64. PubMed ID: 18039018
    [TBL] [Abstract][Full Text] [Related]  

  • 18. KP-103, a novel triazole derivative, is effective in preventing relapse and successfully treating experimental interdigital tinea pedis and tinea corporis in guinea pigs.
    Tatsum Y; Yokoo M; Arika T; Yamaguchi H
    Microbiol Immunol; 2002; 46(7):425-32. PubMed ID: 12222928
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combination treatment of oral terbinafine with topical terbinafine and 10% urea ointment in hyperkeratotic type tinea pedis.
    Shi TW; Zhang JA; Zhang XW; Yu HX; Tang YB; Yu JB
    Mycoses; 2014 Sep; 57(9):560-4. PubMed ID: 24697872
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness and pharmacokinetic study of oral terbinafine for hyperkeratotic-type tinea pedis.
    Kikuchi I; Tanuma H; Morimoto K; Kawana S
    Mycoses; 2008 Nov; 51(6):523-31. PubMed ID: 18422915
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.